SlideShare a Scribd company logo
1 of 37
Tagenarayan Niwaz
January 23, 2015
 Two major goals of testing:
 Diagnosis
 Absence or presence of CAD
 Prognosis
 Determine long-term prognosis or the
risk for an adverse outcome over time
 The performance characteristics of
radionuclide imaging for diagnosis
often are based on an angiographic
definition of stenosis of ≥50 or 70%
stenosis in epicardial vessel
 CAD - more complex process
 Plaque progression/growth
 Stable  unstable plaque transition
 Exertional angina/potential for ACS
 With evolution of preventive measures, testing
has shifted toward assessment of CV risk
and predicting future events
 Risk stratification and assessment of prognosis
by noninvasive imaging –
 reducing risk of MI and cardiac death
 optimizing the selection of patients for
revascularization vs medical therapies
 Goal is to detect patients at risk for:
1. “Hard” cardiac events
 Nonfatal MI, cardiac death, all-cause
mortality
2. “Soft” cardiac events
 Revascularization, hospital admission for
unstable angina or CHF
 More common than hard events
 Low risk - <1% per year risk of hard cardiac
events
 Least likely to benefit from revascularization strategy
 Benefit from medical therapy, risk factor modification
 Intermediate risk - 1% to 3% per year risk
 High risk - >3% per year risk
 Most likely to benefit from revascularization strategy
Extent of perfusion abnormality by stress MPI - important
relationship with subsequent likelihood of an adverse natural
history outcome. A = small defect. B = large defect
Incremental
Prognostic Value
N = 2,200 patients
MPI  Further risk
stratification
Revascularization better if >10% of ischemic myocardium involved
N= 10,000 patients with suspected CAD studied by stress MPI
 Normal study - hard event rate (i.e., rate of
cardiac death or nonfatal MI) occurring during
an average follow-up period of 2 years is
0.7% per year
 Low-risk outcome after a normal MPI study extends
approximately 2 years after testing
 Higher risk in pts w/ prev risk factors (DM, smoking)
 Seen with a board spectrum of isotopes, protocols,
and stressors
 If CAD is present by CATH w/ stable
symptom complex, a normal stress MPI
study result is associated with a low-risk
outcome (Approx 0.9% per year)
 Why normal MPI?
 Preserved endothelial function, allowing
appropriate flow-mediated vasodilation during
stress, reduced impact stenosis on downstream
myocardial perfusion
 Preserved endothelial function - less
susceptible to plaque fissuring or rupture
 Another mechanism may involve the presence
of collateral circulation, allowing normal
stress perfusion in the setting of a stenosis,
and protecting against infarction should the
stenosis become completely occluded
 PET or SPECT assessment - improvement in
stress perfusion after statin therapy
 No change in degree of luminal stenosis but due to
statin-mediated improvement in endothelial
function
 Changes in perfusion – define patients that can
gain benefit from statin therapy in terms of
vascular stability
 Long term follow up needed
Extent Of Ischemia
After Statin
 Angiography - gold standard to detect CAD
 Accuracy of noninvasive testing is based upon:
 Sensitivity
 Percentage of true-positive test results among those with
CAD as defined by angiography
 Specificity
 Percentage of true-negative test results among subjects
without CAD
 Coronary atherosclerosis - complex disease
process
 Involving the coronary arteries diffusely and not
focally
 Underlying disease still present
 Whether a discrete stenotic lesion seen at rest
during Cath results in a perfusion abnormality
during stress
 1. Dependent on the percentage degree of stenosis
 2. Dilatory or constrictor response of the vessel
during stress (mediated by endothelial function)
 3. Presence or absence of collaterals
 Epicardial vessel with 70% stenosis but preserved
endothelial function and collateral supply may have a
normal stress MPI
 False-negative finding b/c CAD exist, reduced MPI
sensitivity
 MPI data - correct physiologic information with
adequet blood flow reserve despite coronary
stenosis
 This example illustrates the limitation of using
angiography as a gold standard in evaluation of a
physiologic modality
 Isolated septal reversible perfusion defects
 Due to flow between the LAD and LCx territories 2/2
to delayed relaxation of the septum in LBBB leading
to reduced coronary flow reserve in early diastole
 See in pts w/ LBBB w/o stenosis of the LAD
 Decrease specificity and predictive value of a septal
perfusion defect with LBBB
 Apical or anterior involvement in septal perfusion
defects increases the specificity for CAD
 Septal defect in LBBB – seen w/ high heart
rates  pharmacologic stress improves
specificity
 Asymmetric septal hypertrophy – seen in HCM,
appearance of greater amount tracer uptake in the
hypertrophied septum relative to the lateral wall
 Lateral wall perfusion defect
 Asymptomatic patients with HCM – can have inducible,
reversible perfusion abnormalities in the absence of
CAD, typically involving the septum
 Possibly related to microvascular abnormalities
 Unfavorable prognosis
Apex consistent with infarction
Hypertrophied septum
Silent Ischemia In The Anterior, Lateral,
And Inferior Wall in HCM
 MPI perfusion abnormalities – can develop in
patients with pressure overload LVH related
to either hypertension or aortic stenosis
 In the absence of CAD – may represent regional
myocardial ischemia based on abnormal
microcirculation and limited vasodilator reserve
 Accuracy of MPI w/ LVH to detect CAD = to pts
without LVH
 ACC/AHA Guidelines: Class I indication for CAD
detection when LVH present
 Abnormalities MPI - common in
patients with dilated
cardiomyopathy despite normal
epicardial coronary arteries
 Likely a result of abnormal coronary
flow reserve
 Worse prognosis, even in the absence
of CAD
 LV systolic dysfunction – MPI help
distinguishing those w/ cardiomyopathy due to
CAD (potentially reversible LV dysfunction) vs
those with Idiopathic, Non Ischemic Dilated
Cardiomyopathy
 Normal MPI  usually excludes CAD as the cause
of the cardiomyopathy
 Abnormal MPI  usually associated with CAD
rather than with Non Ischemic Dilated
Cardiomyopathy
• MPI Stress/Rest in a patient with LV Dysfunction – low
likelihood of CAD
 Abnormalities in myocardial perfusion detected by
SPECT MPI have been demonstrated in patients
with coronary endothelial dysfunction w/o
“significant” epicardial stenosis
 These findings represent true abnormalities in
coronary flow reserve
 Improvement in perfusion on follow-up MPI after
treatment with medical therapies directed at improving
endothelial function
 Data from Cardiac MRI - demonstrating blunted
subendocardial coronary flow reserve in
patients with angina and normal coronary arteries
 2003 ACC/AHA/ASNC Radionuclide Imaging
Guidelines Sensitivity and Specificity
 Metanalysis - 33 studies; 4,480 patients w/ exercise
SPECT imaging
 Sensitivity to detect CAD is 87% (range, 71% to
97%)
 Specificity to rule out CAD is 73% (range, 36% to
100%)
 Limited incorporation of ECG-gated SPECT imaging
of regional function or attenuation correction
 Enhanced specificity
 201Tl (thallium) vs 99mTc-sestamibi - no
significant improvement in sensitivity or
specificity
 Exception - improved specificity in women
with 99mTc-sestamibi vs 201Tl
 99mTc-based agents - greater photon
energy,
 Better for obese patients and those with large
breasts
 Higher-quality gated images
 Intraobserver and Interobserver variability
in the visual analysis of myocardial
perfusion images can occur
 Quantitative analysis of MPI
 Developed to reduce the variability in reading
by
 “Objectifying” image analysis by comparing
regional uptake values against a database of
normal values
 Emory Toolbox,1 Cedars QPS,60 and 4D-
MSPECT
 Compared:
 4DMSPECT (4DM), Emory Cardiac Toolbox (ECTb),
and Cedars Quantitative Perfusion SPECT (QPS)
 N= 1,052 consecutive pts w/ 2-day stress/rest
99mTc-sestamibi MPS studies
 Reference classifications - three physicians, w/
> 25 years of experience in nuclear cardiology
Conclusion: 4D-MSPECT showing the best
performance and Emory Toolbox,1 the worst
Large apical reversible defect
 Sensitivity and Specificity of vasodilator
pharmacologic stress combined with MPI
for the detection of CAD
 Similar to exercise stress
 Lexiscan MPI = Treadmill MPI
 2003 ACC/AHA/ASNC Radionuclide
Imaging Guidelines
 2,465 Patients and 17 studies
 Sensitivity of 89% and specificity of 75%
 Dobutamine Stress- similar to
pharmacologic and exercise stress
modalities for the detection of CAD
 Downsides: Maximal coronary flow reserve is
not achieved as often as with vasodilator
stressors and side effects
 Hence, dobutamine recommended only when
adenosine, dipyridamole, or regadenoson is
contraindicated
 Reactive airways disease
 Sensitivity of MPI highest when the
highest possible level of oxygen demand
is achieved to stimulate the greatest
coronary flow reserve
 For exercise ECG testing - sensitivity
decrease if maximum predicted heart
<85% not achieved
 If unable to reach goal, convert to
pharmacologic test
 Perfusion changes occur at lower degrees of
supply-demand mismatch vs EKG changes
 Sensitivity of MPI to detect CAD seen maintained at
lower workloads
 Pts with CAD - stressed with MPI at a maximal
workload and then again at submaximal workload
 No difference in sensitivity between the maximal and
the submaximal tests
 Extent and severity of reversible perfusion defects were
diminished at submaximal compared with maximal
workloads
 Exercise is the preferred stressor
 Allows for association of symptoms
with perfusion abnormalities
 Incorporation of validated stress test
criteria
 Duke Treadmill Score, heart rate reserve,
or heart rate recovery with the MPI data
Bw's ch. 16 nuclear cardiology   part 4
Bw's ch. 16 nuclear cardiology   part 4

More Related Content

What's hot

Heart in hypertension: Art and Science of Imagery
Heart in hypertension: Art and Science of ImageryHeart in hypertension: Art and Science of Imagery
Heart in hypertension: Art and Science of ImageryMuhammad Ayub
 
Cardiac Pet Power Point
Cardiac Pet Power PointCardiac Pet Power Point
Cardiac Pet Power PointELITE IMAGING
 
Drihabsuliman
DrihabsulimanDrihabsuliman
Drihabsulimanhospital
 
Myocardial perfusion scintigraphy overview
Myocardial perfusion scintigraphy overviewMyocardial perfusion scintigraphy overview
Myocardial perfusion scintigraphy overviewMostafa Sayed
 
Role of nuclear medicine
Role of nuclear medicineRole of nuclear medicine
Role of nuclear medicineLokender Yadav
 
What to choose in stable CAD- Medical therapy only or PCI or CABG?
What to choose in stable CAD- Medical therapy only or PCI or CABG?What to choose in stable CAD- Medical therapy only or PCI or CABG?
What to choose in stable CAD- Medical therapy only or PCI or CABG?cardiositeindia
 
Rate vs rhythm control, what is new in esc 2020
Rate vs rhythm control, what is new in esc 2020Rate vs rhythm control, what is new in esc 2020
Rate vs rhythm control, what is new in esc 2020salah_atta
 
Echocardiography for Acute Coronary Syndrome
Echocardiography for Acute Coronary SyndromeEchocardiography for Acute Coronary Syndrome
Echocardiography for Acute Coronary SyndromePERKI Pekanbaru
 
Year in cardiology imaging 2019 - echocardiography
Year in cardiology imaging 2019 - echocardiographyYear in cardiology imaging 2019 - echocardiography
Year in cardiology imaging 2019 - echocardiographyPraveen Nagula
 
catheter based management of pulmonary embolism
catheter based management of pulmonary embolismcatheter based management of pulmonary embolism
catheter based management of pulmonary embolismAmit Verma
 
Arrhythmia-Induced Cardiomyopathies
Arrhythmia-Induced CardiomyopathiesArrhythmia-Induced Cardiomyopathies
Arrhythmia-Induced Cardiomyopathiesmagdy elmasry
 
Peripheral CTA Imaging
Peripheral CTA Imaging Peripheral CTA Imaging
Peripheral CTA Imaging Sam Watermeier
 
Clinical Applications Of Cardiac Ct
Clinical Applications Of Cardiac CtClinical Applications Of Cardiac Ct
Clinical Applications Of Cardiac CtMuhammad Ayub
 
Acute Coronary Syndrome by Lokeswara Rao Sajja - STAR Hospitals
Acute Coronary Syndrome by Lokeswara Rao Sajja - STAR HospitalsAcute Coronary Syndrome by Lokeswara Rao Sajja - STAR Hospitals
Acute Coronary Syndrome by Lokeswara Rao Sajja - STAR HospitalsStar Hospitals
 

What's hot (20)

Heart in hypertension: Art and Science of Imagery
Heart in hypertension: Art and Science of ImageryHeart in hypertension: Art and Science of Imagery
Heart in hypertension: Art and Science of Imagery
 
Nuclear cardiology
Nuclear cardiologyNuclear cardiology
Nuclear cardiology
 
Cardiac Pet Power Point
Cardiac Pet Power PointCardiac Pet Power Point
Cardiac Pet Power Point
 
Drihabsuliman
DrihabsulimanDrihabsuliman
Drihabsuliman
 
Myocardial perfusion scintigraphy overview
Myocardial perfusion scintigraphy overviewMyocardial perfusion scintigraphy overview
Myocardial perfusion scintigraphy overview
 
Dobutamine stress echo in myocardial viability assessment
Dobutamine stress echo in myocardial viability assessmentDobutamine stress echo in myocardial viability assessment
Dobutamine stress echo in myocardial viability assessment
 
Role of nuclear medicine
Role of nuclear medicineRole of nuclear medicine
Role of nuclear medicine
 
Final acs
Final acsFinal acs
Final acs
 
What to choose in stable CAD- Medical therapy only or PCI or CABG?
What to choose in stable CAD- Medical therapy only or PCI or CABG?What to choose in stable CAD- Medical therapy only or PCI or CABG?
What to choose in stable CAD- Medical therapy only or PCI or CABG?
 
Rate vs rhythm control, what is new in esc 2020
Rate vs rhythm control, what is new in esc 2020Rate vs rhythm control, what is new in esc 2020
Rate vs rhythm control, what is new in esc 2020
 
Echocardiography for Acute Coronary Syndrome
Echocardiography for Acute Coronary SyndromeEchocardiography for Acute Coronary Syndrome
Echocardiography for Acute Coronary Syndrome
 
Year in cardiology imaging 2019 - echocardiography
Year in cardiology imaging 2019 - echocardiographyYear in cardiology imaging 2019 - echocardiography
Year in cardiology imaging 2019 - echocardiography
 
Myocardial viability
Myocardial viabilityMyocardial viability
Myocardial viability
 
catheter based management of pulmonary embolism
catheter based management of pulmonary embolismcatheter based management of pulmonary embolism
catheter based management of pulmonary embolism
 
Arrhythmia-Induced Cardiomyopathies
Arrhythmia-Induced CardiomyopathiesArrhythmia-Induced Cardiomyopathies
Arrhythmia-Induced Cardiomyopathies
 
Peripheral CTA Imaging
Peripheral CTA Imaging Peripheral CTA Imaging
Peripheral CTA Imaging
 
Clinical Applications Of Cardiac Ct
Clinical Applications Of Cardiac CtClinical Applications Of Cardiac Ct
Clinical Applications Of Cardiac Ct
 
Acute Coronary Syndrome by Lokeswara Rao Sajja - STAR Hospitals
Acute Coronary Syndrome by Lokeswara Rao Sajja - STAR HospitalsAcute Coronary Syndrome by Lokeswara Rao Sajja - STAR Hospitals
Acute Coronary Syndrome by Lokeswara Rao Sajja - STAR Hospitals
 
Cardiac petct ahmed tawakol
Cardiac petct ahmed tawakolCardiac petct ahmed tawakol
Cardiac petct ahmed tawakol
 
Device Therapy in Heart Failure
Device Therapy in Heart FailureDevice Therapy in Heart Failure
Device Therapy in Heart Failure
 

Similar to Bw's ch. 16 nuclear cardiology part 4

Patent ductus arteriosus 2014
Patent ductus arteriosus 2014Patent ductus arteriosus 2014
Patent ductus arteriosus 2014Nav Kov
 
Journal review 27 04-2020 1
Journal review 27 04-2020 1Journal review 27 04-2020 1
Journal review 27 04-2020 1Sravan Kumar
 
Management of CKD in Ischemic Heart Disease
Management of CKD in Ischemic Heart DiseaseManagement of CKD in Ischemic Heart Disease
Management of CKD in Ischemic Heart DiseaseMd. Zahirul Islam
 
Esc asymptomatic arrhythmia2019
Esc asymptomatic arrhythmia2019Esc asymptomatic arrhythmia2019
Esc asymptomatic arrhythmia2019Yousra Ghzally
 
CARDIAC COMPLICATIONS & ITS MANAGEMENT OF CKD
CARDIAC COMPLICATIONS & ITS MANAGEMENT OF CKDCARDIAC COMPLICATIONS & ITS MANAGEMENT OF CKD
CARDIAC COMPLICATIONS & ITS MANAGEMENT OF CKDMohd Tariq Ali
 
Intracranial aneurysm surgery and anesthesia
Intracranial aneurysm surgery and anesthesiaIntracranial aneurysm surgery and anesthesia
Intracranial aneurysm surgery and anesthesiaDrManoj Tripathi
 
Cardiovascular complications in CKD - Dr. Mohamed Mamdouh AbdAlBary
Cardiovascular complications in CKD - Dr. Mohamed Mamdouh AbdAlBaryCardiovascular complications in CKD - Dr. Mohamed Mamdouh AbdAlBary
Cardiovascular complications in CKD - Dr. Mohamed Mamdouh AbdAlBaryMNDU net
 
updated Preoperative assessment of noncardiac surgeries
updated Preoperative assessment of noncardiac surgeriesupdated Preoperative assessment of noncardiac surgeries
updated Preoperative assessment of noncardiac surgeriesBasem Enany
 
Non cardiac surgery in cardiac patients mo
Non cardiac surgery in cardiac patients moNon cardiac surgery in cardiac patients mo
Non cardiac surgery in cardiac patients moTamer Taha
 
Preop cardiovascular evaluation
Preop cardiovascular evaluationPreop cardiovascular evaluation
Preop cardiovascular evaluationBrijesh Savidhan
 
Hemodynamic monitoring- Dr Sandeep Gampa
Hemodynamic monitoring- Dr Sandeep GampaHemodynamic monitoring- Dr Sandeep Gampa
Hemodynamic monitoring- Dr Sandeep GampaSiddharth Pandey
 
Seminar presentation 7
Seminar presentation 7Seminar presentation 7
Seminar presentation 7SumaiyaShams
 
An Unusual Cause of Left Ventricular Volume Overload after Aortic Valve Repla...
An Unusual Cause of Left Ventricular Volume Overload after Aortic Valve Repla...An Unusual Cause of Left Ventricular Volume Overload after Aortic Valve Repla...
An Unusual Cause of Left Ventricular Volume Overload after Aortic Valve Repla...escardio
 
Perioperative myocardial infarction ppt
Perioperative myocardial infarction pptPerioperative myocardial infarction ppt
Perioperative myocardial infarction pptYogasundaram Sasikumar
 
Board Simulation Cardiology-1.pptx
Board Simulation Cardiology-1.pptxBoard Simulation Cardiology-1.pptx
Board Simulation Cardiology-1.pptxLaithLutfi1
 
Acute Decompensated Heart Failure : What is New ?
Acute Decompensated Heart Failure : What is New ?Acute Decompensated Heart Failure : What is New ?
Acute Decompensated Heart Failure : What is New ?drucsamal
 
Appropriteness Criteria for Coronary Revascularization
Appropriteness Criteria for Coronary RevascularizationAppropriteness Criteria for Coronary Revascularization
Appropriteness Criteria for Coronary RevascularizationLalit Kapoor
 

Similar to Bw's ch. 16 nuclear cardiology part 4 (20)

Patent ductus arteriosus 2014
Patent ductus arteriosus 2014Patent ductus arteriosus 2014
Patent ductus arteriosus 2014
 
Journal review 27 04-2020 1
Journal review 27 04-2020 1Journal review 27 04-2020 1
Journal review 27 04-2020 1
 
Management of CKD in Ischemic Heart Disease
Management of CKD in Ischemic Heart DiseaseManagement of CKD in Ischemic Heart Disease
Management of CKD in Ischemic Heart Disease
 
Esc asymptomatic arrhythmia2019
Esc asymptomatic arrhythmia2019Esc asymptomatic arrhythmia2019
Esc asymptomatic arrhythmia2019
 
CARDIAC COMPLICATIONS & ITS MANAGEMENT OF CKD
CARDIAC COMPLICATIONS & ITS MANAGEMENT OF CKDCARDIAC COMPLICATIONS & ITS MANAGEMENT OF CKD
CARDIAC COMPLICATIONS & ITS MANAGEMENT OF CKD
 
Intracranial aneurysm surgery and anesthesia
Intracranial aneurysm surgery and anesthesiaIntracranial aneurysm surgery and anesthesia
Intracranial aneurysm surgery and anesthesia
 
Aneurysm
AneurysmAneurysm
Aneurysm
 
ANES 1502 - M9 PPT: Fundamentals of Critical Care
ANES 1502 - M9 PPT: Fundamentals of Critical CareANES 1502 - M9 PPT: Fundamentals of Critical Care
ANES 1502 - M9 PPT: Fundamentals of Critical Care
 
Carotid stenting
Carotid stentingCarotid stenting
Carotid stenting
 
Cardiovascular complications in CKD - Dr. Mohamed Mamdouh AbdAlBary
Cardiovascular complications in CKD - Dr. Mohamed Mamdouh AbdAlBaryCardiovascular complications in CKD - Dr. Mohamed Mamdouh AbdAlBary
Cardiovascular complications in CKD - Dr. Mohamed Mamdouh AbdAlBary
 
updated Preoperative assessment of noncardiac surgeries
updated Preoperative assessment of noncardiac surgeriesupdated Preoperative assessment of noncardiac surgeries
updated Preoperative assessment of noncardiac surgeries
 
Non cardiac surgery in cardiac patients mo
Non cardiac surgery in cardiac patients moNon cardiac surgery in cardiac patients mo
Non cardiac surgery in cardiac patients mo
 
Preop cardiovascular evaluation
Preop cardiovascular evaluationPreop cardiovascular evaluation
Preop cardiovascular evaluation
 
Hemodynamic monitoring- Dr Sandeep Gampa
Hemodynamic monitoring- Dr Sandeep GampaHemodynamic monitoring- Dr Sandeep Gampa
Hemodynamic monitoring- Dr Sandeep Gampa
 
Seminar presentation 7
Seminar presentation 7Seminar presentation 7
Seminar presentation 7
 
An Unusual Cause of Left Ventricular Volume Overload after Aortic Valve Repla...
An Unusual Cause of Left Ventricular Volume Overload after Aortic Valve Repla...An Unusual Cause of Left Ventricular Volume Overload after Aortic Valve Repla...
An Unusual Cause of Left Ventricular Volume Overload after Aortic Valve Repla...
 
Perioperative myocardial infarction ppt
Perioperative myocardial infarction pptPerioperative myocardial infarction ppt
Perioperative myocardial infarction ppt
 
Board Simulation Cardiology-1.pptx
Board Simulation Cardiology-1.pptxBoard Simulation Cardiology-1.pptx
Board Simulation Cardiology-1.pptx
 
Acute Decompensated Heart Failure : What is New ?
Acute Decompensated Heart Failure : What is New ?Acute Decompensated Heart Failure : What is New ?
Acute Decompensated Heart Failure : What is New ?
 
Appropriteness Criteria for Coronary Revascularization
Appropriteness Criteria for Coronary RevascularizationAppropriteness Criteria for Coronary Revascularization
Appropriteness Criteria for Coronary Revascularization
 

Bw's ch. 16 nuclear cardiology part 4

  • 2.  Two major goals of testing:  Diagnosis  Absence or presence of CAD  Prognosis  Determine long-term prognosis or the risk for an adverse outcome over time
  • 3.  The performance characteristics of radionuclide imaging for diagnosis often are based on an angiographic definition of stenosis of ≥50 or 70% stenosis in epicardial vessel  CAD - more complex process  Plaque progression/growth  Stable  unstable plaque transition  Exertional angina/potential for ACS
  • 4.  With evolution of preventive measures, testing has shifted toward assessment of CV risk and predicting future events  Risk stratification and assessment of prognosis by noninvasive imaging –  reducing risk of MI and cardiac death  optimizing the selection of patients for revascularization vs medical therapies
  • 5.  Goal is to detect patients at risk for: 1. “Hard” cardiac events  Nonfatal MI, cardiac death, all-cause mortality 2. “Soft” cardiac events  Revascularization, hospital admission for unstable angina or CHF  More common than hard events
  • 6.  Low risk - <1% per year risk of hard cardiac events  Least likely to benefit from revascularization strategy  Benefit from medical therapy, risk factor modification  Intermediate risk - 1% to 3% per year risk  High risk - >3% per year risk  Most likely to benefit from revascularization strategy
  • 7. Extent of perfusion abnormality by stress MPI - important relationship with subsequent likelihood of an adverse natural history outcome. A = small defect. B = large defect
  • 8. Incremental Prognostic Value N = 2,200 patients MPI  Further risk stratification
  • 9. Revascularization better if >10% of ischemic myocardium involved N= 10,000 patients with suspected CAD studied by stress MPI
  • 10.  Normal study - hard event rate (i.e., rate of cardiac death or nonfatal MI) occurring during an average follow-up period of 2 years is 0.7% per year  Low-risk outcome after a normal MPI study extends approximately 2 years after testing  Higher risk in pts w/ prev risk factors (DM, smoking)  Seen with a board spectrum of isotopes, protocols, and stressors
  • 11.  If CAD is present by CATH w/ stable symptom complex, a normal stress MPI study result is associated with a low-risk outcome (Approx 0.9% per year)  Why normal MPI?  Preserved endothelial function, allowing appropriate flow-mediated vasodilation during stress, reduced impact stenosis on downstream myocardial perfusion  Preserved endothelial function - less susceptible to plaque fissuring or rupture
  • 12.  Another mechanism may involve the presence of collateral circulation, allowing normal stress perfusion in the setting of a stenosis, and protecting against infarction should the stenosis become completely occluded
  • 13.  PET or SPECT assessment - improvement in stress perfusion after statin therapy  No change in degree of luminal stenosis but due to statin-mediated improvement in endothelial function  Changes in perfusion – define patients that can gain benefit from statin therapy in terms of vascular stability  Long term follow up needed
  • 15.  Angiography - gold standard to detect CAD  Accuracy of noninvasive testing is based upon:  Sensitivity  Percentage of true-positive test results among those with CAD as defined by angiography  Specificity  Percentage of true-negative test results among subjects without CAD
  • 16.  Coronary atherosclerosis - complex disease process  Involving the coronary arteries diffusely and not focally  Underlying disease still present  Whether a discrete stenotic lesion seen at rest during Cath results in a perfusion abnormality during stress  1. Dependent on the percentage degree of stenosis  2. Dilatory or constrictor response of the vessel during stress (mediated by endothelial function)  3. Presence or absence of collaterals
  • 17.  Epicardial vessel with 70% stenosis but preserved endothelial function and collateral supply may have a normal stress MPI  False-negative finding b/c CAD exist, reduced MPI sensitivity  MPI data - correct physiologic information with adequet blood flow reserve despite coronary stenosis  This example illustrates the limitation of using angiography as a gold standard in evaluation of a physiologic modality
  • 18.  Isolated septal reversible perfusion defects  Due to flow between the LAD and LCx territories 2/2 to delayed relaxation of the septum in LBBB leading to reduced coronary flow reserve in early diastole  See in pts w/ LBBB w/o stenosis of the LAD  Decrease specificity and predictive value of a septal perfusion defect with LBBB  Apical or anterior involvement in septal perfusion defects increases the specificity for CAD  Septal defect in LBBB – seen w/ high heart rates  pharmacologic stress improves specificity
  • 19.  Asymmetric septal hypertrophy – seen in HCM, appearance of greater amount tracer uptake in the hypertrophied septum relative to the lateral wall  Lateral wall perfusion defect  Asymptomatic patients with HCM – can have inducible, reversible perfusion abnormalities in the absence of CAD, typically involving the septum  Possibly related to microvascular abnormalities  Unfavorable prognosis
  • 20. Apex consistent with infarction Hypertrophied septum Silent Ischemia In The Anterior, Lateral, And Inferior Wall in HCM
  • 21.  MPI perfusion abnormalities – can develop in patients with pressure overload LVH related to either hypertension or aortic stenosis  In the absence of CAD – may represent regional myocardial ischemia based on abnormal microcirculation and limited vasodilator reserve  Accuracy of MPI w/ LVH to detect CAD = to pts without LVH  ACC/AHA Guidelines: Class I indication for CAD detection when LVH present
  • 22.  Abnormalities MPI - common in patients with dilated cardiomyopathy despite normal epicardial coronary arteries  Likely a result of abnormal coronary flow reserve  Worse prognosis, even in the absence of CAD
  • 23.  LV systolic dysfunction – MPI help distinguishing those w/ cardiomyopathy due to CAD (potentially reversible LV dysfunction) vs those with Idiopathic, Non Ischemic Dilated Cardiomyopathy  Normal MPI  usually excludes CAD as the cause of the cardiomyopathy  Abnormal MPI  usually associated with CAD rather than with Non Ischemic Dilated Cardiomyopathy
  • 24. • MPI Stress/Rest in a patient with LV Dysfunction – low likelihood of CAD
  • 25.  Abnormalities in myocardial perfusion detected by SPECT MPI have been demonstrated in patients with coronary endothelial dysfunction w/o “significant” epicardial stenosis  These findings represent true abnormalities in coronary flow reserve  Improvement in perfusion on follow-up MPI after treatment with medical therapies directed at improving endothelial function  Data from Cardiac MRI - demonstrating blunted subendocardial coronary flow reserve in patients with angina and normal coronary arteries
  • 26.  2003 ACC/AHA/ASNC Radionuclide Imaging Guidelines Sensitivity and Specificity  Metanalysis - 33 studies; 4,480 patients w/ exercise SPECT imaging  Sensitivity to detect CAD is 87% (range, 71% to 97%)  Specificity to rule out CAD is 73% (range, 36% to 100%)  Limited incorporation of ECG-gated SPECT imaging of regional function or attenuation correction  Enhanced specificity
  • 27.  201Tl (thallium) vs 99mTc-sestamibi - no significant improvement in sensitivity or specificity  Exception - improved specificity in women with 99mTc-sestamibi vs 201Tl  99mTc-based agents - greater photon energy,  Better for obese patients and those with large breasts  Higher-quality gated images
  • 28.  Intraobserver and Interobserver variability in the visual analysis of myocardial perfusion images can occur  Quantitative analysis of MPI  Developed to reduce the variability in reading by  “Objectifying” image analysis by comparing regional uptake values against a database of normal values  Emory Toolbox,1 Cedars QPS,60 and 4D- MSPECT
  • 29.  Compared:  4DMSPECT (4DM), Emory Cardiac Toolbox (ECTb), and Cedars Quantitative Perfusion SPECT (QPS)  N= 1,052 consecutive pts w/ 2-day stress/rest 99mTc-sestamibi MPS studies  Reference classifications - three physicians, w/ > 25 years of experience in nuclear cardiology Conclusion: 4D-MSPECT showing the best performance and Emory Toolbox,1 the worst
  • 31.  Sensitivity and Specificity of vasodilator pharmacologic stress combined with MPI for the detection of CAD  Similar to exercise stress  Lexiscan MPI = Treadmill MPI  2003 ACC/AHA/ASNC Radionuclide Imaging Guidelines  2,465 Patients and 17 studies  Sensitivity of 89% and specificity of 75%
  • 32.  Dobutamine Stress- similar to pharmacologic and exercise stress modalities for the detection of CAD  Downsides: Maximal coronary flow reserve is not achieved as often as with vasodilator stressors and side effects  Hence, dobutamine recommended only when adenosine, dipyridamole, or regadenoson is contraindicated  Reactive airways disease
  • 33.  Sensitivity of MPI highest when the highest possible level of oxygen demand is achieved to stimulate the greatest coronary flow reserve  For exercise ECG testing - sensitivity decrease if maximum predicted heart <85% not achieved  If unable to reach goal, convert to pharmacologic test
  • 34.  Perfusion changes occur at lower degrees of supply-demand mismatch vs EKG changes  Sensitivity of MPI to detect CAD seen maintained at lower workloads  Pts with CAD - stressed with MPI at a maximal workload and then again at submaximal workload  No difference in sensitivity between the maximal and the submaximal tests  Extent and severity of reversible perfusion defects were diminished at submaximal compared with maximal workloads
  • 35.  Exercise is the preferred stressor  Allows for association of symptoms with perfusion abnormalities  Incorporation of validated stress test criteria  Duke Treadmill Score, heart rate reserve, or heart rate recovery with the MPI data

Editor's Notes

  1. This definition of CAD is in part based on seminal studies in animal models showing that a 50% stenosis begins to blunt coronary flow reserve
  2. Prognostic implications of myocardial perfusion imaging. Middle panel,Cardiac event rate (risk of cardiac death or MI) during long-term follow-up plotted as a function of the extent of inducible ischemia (the number of reversible perfusion defects). There is an exponential relationship between the extent of ischemia and the risk of a cardiac event.   A, B, SPECT perfusion images in two patients with stable anginal symptoms.A, Small area of inferoapical ischemia (arrows). When this extent of ischemia is plotted on the graph (line to red circle), the patient is placed in a low-risk  In two older men with typical exertional angina, it would be predicted that the probability of CAD is very high, according to established guidelines. What is not established from the clinical information, however, is the risk of cardiac events. This example demonstrates that patients presenting with similar symptoms might be identified as having specific natural histories on the basis of perfusion imaging data, with distinct implications for subsequent management.
  3. Stress MPI data have been shown to have incremental prognostic value when added to prognostic stress ECG instruments such as the Duke Treadmill Score, a well-validated instrument incorporating symptoms, treadmill performance, and stress ECG findings to predict natural history outcomes. With use of the Duke Treadmill Score information alone, the management of low-risk patients probably would be conservative, and the management of high-risk patients would be likely to involve revascularization. The optimal management of intermediate-risk patients is unclear, but many probably would be referred for catheterization. In almost 70% of the patients in the intermediate Duke Treadmill Score category, however, stress perfusion study findings were normal (Fig. 16-31A), associated with a very-low-risk natural history, implying that conservative management would be a safe and effective strategy.
  4. In a group of more than 10,000 patients with suspected CAD studied by stress MPI, the extent of ischemic myocardium predicted reduction in the risk of death with revascularization compared with medical therapy (Fig. 16-32), beginning at just over 10% of ischemic myocardium. As the percentage of ischemic myocardium increased, the magnitude of benefit of revascularization increased as well. Thus MPI data can predict the magnitude of a potential treatment benefit from revascularization, helping to guide management decisions.
  5. PET imaging: Baseline, 6 weeks, 6 months. Extent of ischemia
  6. Due to flow between the LAD and left circumflex territories 2/2 to delayed relaxation of the septum in LBBB leading to reduced coronary flow reserve in early diastole, or reduced oxygen demand as a result of late septal contraction when wall stress is decreasing Septal defect in LBBB – seen w/ high heart rates  pharmacologic stress improves specificity, and vasodilator stress is recommended in the setting of LBBB
  7. Asymptomatic patients with HCM – can have inducible, reversible perfusion abnormalities in the absence of CAD, typically involving the septum. May represent ischemia possibly related to microvascular abnormalities and have low specificity for CAD. The blunted coronary flow reserve in patients with HCM is associated with a more unfavorable natural history
  8. Fixed perfusion defect of the apex consistent with infarction, indicated by yellow arrowheads in the horizontal (HLA) and vertical (VLA) long-axis images, with a reversible defect of the anterior wall (yellow arrows in the VLA images). The hypertrophied septum is evident (white arrows in the HLA images). B,Extensive inducible silent ischemia in the anterior, lateral, and inferior walls (white arrows). 
  9. On the basis of such data, MPI is an ACC/AHA Guidelines class I indication for CAD detection when LVH is present on the ECG SPECT imaging data in patients with LVH also have a risk stratification value similar to that in patients without LVH
  10. Although many patients with DCM may have perfusion abnormalities detected on MPI, the absence of perfusion abnormalities usually excludes CAD as the cause of the cardiomyopathy Perfusion abnormalities in the setting of LV dysfunction – usually associated with CAD rather than with DCM
  11. SPECT perfusion images at stress and rest from a patient with heart failure. The images depict a dilated left ventricle but with normal perfusion patterns, suggesting a low likelihood that coronary artery disease is the cause of heart failure. HLA = horizontal long axis; SA = short axis; VLA = vertical long axis.
  12. Automated quantitative analysis software. Selected short- and long-axis tomograms from stress and rest studies (two left columns) are automatically segmented and scored. Bull’s-eye plots are created (third column) representing the stress (top) and rest (middle) data and demonstrate. The bottom bull’s-eye plot displays the extent of ischemic myocardium (white area), which measures 23% of the total myocardium. The bull’s-eye information is also displayed in a three-dimensional format (right column, top, middle, and bottom, respectively).
  13. A pooled analysis from the 2003 ACC/AHA/ASNC Radionuclide Imaging Guidelines involving 2465 catheterized patients in 17 studies6demonstrated sensitivity of 89% and specificity of 75%